The inhibitor of apoptosis proteins antagonist Debio 1143 promotes the PD-1 blockade-mediated HIV load reduction in blood and tissues of humanized mice

• Michael Bobardt,

  Roles Investigation

  Affiliation Department of Immunology & Microbiology, The Scripps Research Institute, La Jolla, California, United States of America

  ⨯
• Joseph Kuo,

  Roles Formal analysis

  Affiliation Department of Immunology & Microbiology, The Scripps Research Institute, La Jolla, California, United States of America

  ⨯
• Udayan Chatterji,

  Roles Investigation

  Affiliation Department of Immunology & Microbiology, The Scripps Research Institute, La Jolla, California, United States of America

  ⨯
• Norbert Wiedemann,

  Roles Conceptualization, Writing – review & editing

  Affiliation Debiopharm International S.A., Lausanne, Switzerland

  ⨯
• Gregoire Vuagniaux,

  Roles Conceptualization, Writing – review & editing

  Affiliation Debiopharm International S.A., Lausanne, Switzerland

  ⨯
• Philippe Gallay

  Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Project administration, Supervision, Validation, Visualization, Writing – original draft

  * E-mail: gallay@scripps.edu

  Affiliation Department of Immunology & Microbiology, The Scripps Research Institute, La Jolla, California, United States of America

  http://orcid.org/0000-0002-6151-4764

  ⨯